KNSA - Kiniksa Pharmaceuticals GAAP EPS of -$0.20 misses by $0.03 revenue of $67.05M beats by $2.6M
2023-10-31 07:44:41 ET
More on Kiniksa Pharmaceuticals
- Kiniksa's Diversified Pipeline Augments Arcalyst Potential
- Seeking Alpha’s Quant Rating on Kiniksa Pharmaceuticals
- Historical earnings data for Kiniksa Pharmaceuticals
- Financial information for Kiniksa Pharmaceuticals
For further details see:
Kiniksa Pharmaceuticals GAAP EPS of -$0.20 misses by $0.03, revenue of $67.05M beats by $2.6M